SCHEMBL22892255

SCHEMBL22892255

CCC(=O)N1CCN(c2cc(C)c(Cl)cc2OC)CC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.53
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
MAPT P10636 2/20 0.47
RECQL P46063 1/20 0.47
ALDH1A1 P00352 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPK1 P28482 2/20 0.44
LMNA P02545 2/20 0.44
HTT P42858 1/20 0.44
HTR1A P08908 1/20 0.43
HTR1D P28221 1/20 0.43
HTR1B P28222 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.43
ALK Q9UM73 1/20 0.43
POLB P06746 1/20 0.43
CCR1 P32246 1/20 0.43
USP2 O75604 1/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22892248 0.91 TSHR (0.50) TSHRMEN1KMT2AMAPTRECQL
SCHEMBL22892378 0.90 MAPT (0.49) TSHRMEN1KMT2AMAPTRECQL
SCHEMBL22892383 0.87 MEN1 (0.47) TSHRMEN1KMT2AMAPTRECQL
SCHEMBL22892269 0.85 TSHR (0.56) TSHRMEN1KMT2AMAPTRECQL
SCHEMBL22892259 0.81 LMNA (0.59) TSHRMEN1KMT2AMAPTALDH1A1
SCHEMBL22892249 0.81 TSHR (0.62) TSHRMEN1KMT2AMAPTRECQL
SCHEMBL22062951 0.78 ADAM17 (0.63) TSHRMEN1KMT2AALDH1A1ADAMTS5
SCHEMBL19691523 0.77 ADAMTS5 (0.76) ADAMTS5
SCHEMBL22892230 0.77 MEN1 (0.56) TSHRMEN1KMT2AMAPTRECQL
SCHEMBL19002655 0.76 MAPT (0.68) TSHRMEN1KMT2AMAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3468955-B1 5-[3-[PIPERAZIN-1-YL]-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS 4 AND 5 INHIBITORS FOR TREATING E.G. OSTEOARTHRITIS GALAPAGOS NV (BE) 2021-01-06 EP disclosed